Stay updated on Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removal of v3.2.0; these are metadata about revisions rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedA government funding notice explaining potential delays and operating status was removed from the page. The removal does not affect the study data or how to navigate the page.SummaryDifference0.7%

- Check47 days agoChange DetectedDifference0.8%

- Check62 days agoChange DetectedAdds a comprehensive study documentation section (status, design, outcome measures, participant flow, results, adverse events, quality control) with a return date, signaling ongoing research activity.SummaryDifference4%

- Check76 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference13%

- Check83 days agoChange DetectedResults have moved from no results posted to results submitted, with a new version tag v3.1.0 replacing v3.0.2.SummaryDifference0.8%

Stay in the know with updates to Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.